A Study to Evaluate the Efficacy and Safety of Gemigliptin With in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: Gemigliptin 50mg; Drug: Gemigliptin Placebo Sponsor: LG Chem Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Forxiga | Metformin | Research | Study